Suppr超能文献

通过抗原捕获/聚合酶链反应检测凝血因子VIII制剂中的甲型肝炎病毒。

Detection of hepatitis A virus in a factor VIII preparation by antigen capture/PCR.

作者信息

Normann A, Graff J, Flehmig B

机构信息

Department of Medical Virology and Epidemiology of Virus Diseases, University of Tübingen, FRG.

出版信息

Vox Sang. 1994;67 Suppl 1:57-60; discussion 61.

PMID:8091739
Abstract

The antigen capture/PCR (AC/PCR) has been applied in the analysis of various factor VIII preparations, which were suspected to be contaminated with hepatitis A virus (HAV). AC/PCR involves capturing the antigen, i.e. the intact virus particles, by binding to the HAV monoclonal antibody mAb 7e7, reverse transcription of the viral RNA and amplification of the cDNA with HAV-specific primer pairs. The PCR analysis of one factor VIII concentrate yielded an HAV-specific DNA product, which could be confirmed by Southern blot analysis. The HAV strain recovered by AC/PCR from this factor VIII concentrate could be classified into genotype III after solid-phase sequencing of the product and comparison with the consensus sequences for the known HAV genotypes. Analysis of the sera from 3 haemophiliacs treated with this batch has not resulted in a reliable product. However, the results obtained indicate that HAV can be detected in purified factor VIII preparations by AC/PCR.

摘要

抗原捕获/聚合酶链反应(AC/PCR)已应用于各种VIII因子制剂的分析,这些制剂被怀疑受到甲型肝炎病毒(HAV)污染。AC/PCR包括通过与HAV单克隆抗体mAb 7e7结合捕获抗原,即完整的病毒颗粒,逆转录病毒RNA并用HAV特异性引物对扩增cDNA。对一种VIII因子浓缩物的PCR分析产生了一种HAV特异性DNA产物,该产物可通过Southern印迹分析得到证实。通过AC/PCR从该VIII因子浓缩物中回收的HAV毒株,在对产物进行固相测序并与已知HAV基因型的共有序列比较后,可归类为III型。对3名接受该批次治疗的血友病患者的血清分析未得到可靠结果。然而,所获得的结果表明,通过AC/PCR可以在纯化的VIII因子制剂中检测到HAV。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验